|
Sign In to gain access to subscriptions and/or personal tools.
|
Pituitary failure, metformin and hypoglycaemia in type 2 diabetes
Paul J Newey
John Radcliffe Hospital, Headley Way, Oxford, Headington, OX3 9DU, UK
Youssif Abousleiman
Queen Margaret Hospital, Dunfermline, Fife, KY12 0SU, Scotland
Andrew Jamieson
Hairmyres Hospital, Eaglesham Road, East Kilbride, Glasgow, G75 8RG, Scotland, drandrew.jamieson{at}btopenworld.com
References
- UK Prospective Diabetes Study (UKPDS) Group. Effects of intensive blood-glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jones GC, Macklin JP, Alexander WD Contraindications to the use of metformin. BMJ 2003;326:4-5.[Free Full Text]
- Tattersall RB Frequency, causes and treatment of hypoglycaemia. In: Frier BM and Fisher BM (eds), Hypoglycaemia in clinical diabetes. 1999. Chichester: Wiley and Sons: pp 55-87.
- Salpeter S., Greyber E., Pasternak G., Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus (Cochrane Review). Cochrane Database Syst Rev 2003;(2):CD002967.
- Howlett HCS, Bailey CJ A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Safety 1999;20:489-503.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Seltzer HS Drug-induced hypoglycaemia. A review of 1418 cases. Endocrinol Metab Clin North Am 1989;18(1):163-83.[Web of Science][Medline]
[Order article via Infotrieve]
The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 2,
128-130 (2004)
DOI: 10.1177/14746514040040021201

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|